Arkansas ac­cus­es Eli Lil­ly, No­vo Nordisk, and Sanofi of col­lud­ing to dri­ve up in­sulin prices

Arkansas brought Eli Lil­ly, No­vo Nordisk, Sanofi, and three of the largest phar­ma­cy ben­e­fit man­agers (PBMs) to court yes­ter­day, ac­cus­ing them of col­lud­ing to ar­ti­fi­cial­ly dri­ve up in­sulin prices.

The com­plaint, filed by Arkansas At­tor­ney Gen­er­al Leslie Rut­ledge, al­leges the de­fen­dants de­vised a scheme in which the Big Phar­mas would “ar­ti­fi­cial­ly and will­ing­ly raise their list prices” and then pay a part of those earn­ings back to the PBMs as re­bates.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER